Eversheds Sutherland has advised the seller of BioSalma
December 16, 2025
Eversheds Sutherland has advised the seller of BioSalmaDecember 16, 2025 Eversheds Sutherland Sweden has advised the seller of BioSalma AB in connection with the divestment to Vision Healthcare. BioSalma is a Swedish health and wellness brand offering a wide portfolio of vitamins, minerals, and nutritional supplements developed with a focus on quality, purity, and scientific rigor. With a strong presence in online pharmacies and physical retail & pharma chains, BioSalma serves a broad and loyal customer base across the Nordic region. Vision Healthcare is a Belgium based digital-first omni-channel platform dedicated to self-care and health-focused brands across Europe. With a strong foundation in consumer health, the company focuses on building innovative brands and delivering high-quality, science-backed products that support everyday wellbeing. Eversheds Sutherland’s team consisted of Jens André, Therése Berg, Gustav Dahlsjö, Matilda Frykman Krans, Rebecca Hayling and Sabrina Ibrisevic. Key contacts
Latest Insights
Latest News
Latest Events
firm news July 10, 2026 Eversheds Sutherland advises OCBC on the landmark secondary dual listing of... client news July 10, 2026 Setting sail: Eversheds Sutherland advises senior management of D-Marin on ... client news July 09, 2026 Eversheds Sutherland advises Costello Medical on transition to employee own... firm news July 01, 2026 Eversheds Sutherland lands lateral partner-led Paris Funds team, as its wid... virtual UAE - Employment law in the Dubai International Financial Centre September 10, 2026 9.30am - 1.30pm (GMT) Virtual in-person September 10, 2026 9.30am - 1.00pm (BST) London, United Kingdom in-person September 17, 2026 9.30am - 4.30pm (GMT) London, United Kingdom in-person September 23, 2026 Washington DC, United States |